In Vitro and In Vivo Characterization of the Non-peptide N K3 Receptor Antagonist SB-223412 (Talnetant) : Potential Therapeutic Utility in the Treatment of Schizophrenia
Gespeichert in:
| Veröffentlicht in: | Neuropsychopharmacology (New York, N.Y.) N.Y.), 2008, Vol.33 (7), p.1642-1652 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1652 |
|---|---|
| container_issue | 7 |
| container_start_page | 1642 |
| container_title | Neuropsychopharmacology (New York, N.Y.) |
| container_volume | 33 |
| creator | DAWSON, Lee A CATO, Katherine J SOUTHAM, Eric MURKITT, Graham S GARTLON, Jane PEMBERTON, Darrel J JONES, Declan N. C DAVIES, Ceri H HAGAN, Jim SCOTT, Claire WATSON, Jeannette M WOOD, Martyn D FOXTON, Richard DE LA FLOR, Raul JONES, Gareth A KEW, James N. C CLUDERAY, Jane E |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_20344101</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20344101</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_203441013</originalsourceid><addsrcrecordid>eNqNjd1KAzEQRoMouP68w9wIerGQbNa2eqdFqQgidpXelSHNuiPbSUhGoX0j39K1-ABefd-BA2dPFWZc63Jk68W-KvTkypbG2sWhOsr5Q2tzOR5NCvX9wPBGkgIgr2AHXwGmHSZ04hNtUSgwhBak8_AUuIw-Cq2GD48WXrwbMCS4YcH3wJQF5rdlVdnaVHDeYM9ekOUCruE5iGch7KHpfMLoP4UcvAr1JBsg3hWa5FHWg_ebnLuOtiF2yTPhiTposc_-9G-P1dn9XTOdlRGzw75NyI7yMiZaY9osK23r2mhj_-v9AHCOYH4</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>In Vitro and In Vivo Characterization of the Non-peptide N K3 Receptor Antagonist SB-223412 (Talnetant) : Potential Therapeutic Utility in the Treatment of Schizophrenia</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>DAWSON, Lee A ; CATO, Katherine J ; SOUTHAM, Eric ; MURKITT, Graham S ; GARTLON, Jane ; PEMBERTON, Darrel J ; JONES, Declan N. C ; DAVIES, Ceri H ; HAGAN, Jim ; SCOTT, Claire ; WATSON, Jeannette M ; WOOD, Martyn D ; FOXTON, Richard ; DE LA FLOR, Raul ; JONES, Gareth A ; KEW, James N. C ; CLUDERAY, Jane E</creator><creatorcontrib>DAWSON, Lee A ; CATO, Katherine J ; SOUTHAM, Eric ; MURKITT, Graham S ; GARTLON, Jane ; PEMBERTON, Darrel J ; JONES, Declan N. C ; DAVIES, Ceri H ; HAGAN, Jim ; SCOTT, Claire ; WATSON, Jeannette M ; WOOD, Martyn D ; FOXTON, Richard ; DE LA FLOR, Raul ; JONES, Gareth A ; KEW, James N. C ; CLUDERAY, Jane E</creatorcontrib><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>CODEN: NEROEW</identifier><language>eng</language><publisher>New York, NY: Nature Publishing</publisher><subject>Adult and adolescent clinical studies ; Biological and medical sciences ; Medical sciences ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Schizophrenia</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2008, Vol.33 (7), p.1642-1652</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,4026</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20344101$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>DAWSON, Lee A</creatorcontrib><creatorcontrib>CATO, Katherine J</creatorcontrib><creatorcontrib>SOUTHAM, Eric</creatorcontrib><creatorcontrib>MURKITT, Graham S</creatorcontrib><creatorcontrib>GARTLON, Jane</creatorcontrib><creatorcontrib>PEMBERTON, Darrel J</creatorcontrib><creatorcontrib>JONES, Declan N. C</creatorcontrib><creatorcontrib>DAVIES, Ceri H</creatorcontrib><creatorcontrib>HAGAN, Jim</creatorcontrib><creatorcontrib>SCOTT, Claire</creatorcontrib><creatorcontrib>WATSON, Jeannette M</creatorcontrib><creatorcontrib>WOOD, Martyn D</creatorcontrib><creatorcontrib>FOXTON, Richard</creatorcontrib><creatorcontrib>DE LA FLOR, Raul</creatorcontrib><creatorcontrib>JONES, Gareth A</creatorcontrib><creatorcontrib>KEW, James N. C</creatorcontrib><creatorcontrib>CLUDERAY, Jane E</creatorcontrib><title>In Vitro and In Vivo Characterization of the Non-peptide N K3 Receptor Antagonist SB-223412 (Talnetant) : Potential Therapeutic Utility in the Treatment of Schizophrenia</title><title>Neuropsychopharmacology (New York, N.Y.)</title><subject>Adult and adolescent clinical studies</subject><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Schizophrenia</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNjd1KAzEQRoMouP68w9wIerGQbNa2eqdFqQgidpXelSHNuiPbSUhGoX0j39K1-ABefd-BA2dPFWZc63Jk68W-KvTkypbG2sWhOsr5Q2tzOR5NCvX9wPBGkgIgr2AHXwGmHSZ04hNtUSgwhBak8_AUuIw-Cq2GD48WXrwbMCS4YcH3wJQF5rdlVdnaVHDeYM9ekOUCruE5iGch7KHpfMLoP4UcvAr1JBsg3hWa5FHWg_ebnLuOtiF2yTPhiTposc_-9G-P1dn9XTOdlRGzw75NyI7yMiZaY9osK23r2mhj_-v9AHCOYH4</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>DAWSON, Lee A</creator><creator>CATO, Katherine J</creator><creator>SOUTHAM, Eric</creator><creator>MURKITT, Graham S</creator><creator>GARTLON, Jane</creator><creator>PEMBERTON, Darrel J</creator><creator>JONES, Declan N. C</creator><creator>DAVIES, Ceri H</creator><creator>HAGAN, Jim</creator><creator>SCOTT, Claire</creator><creator>WATSON, Jeannette M</creator><creator>WOOD, Martyn D</creator><creator>FOXTON, Richard</creator><creator>DE LA FLOR, Raul</creator><creator>JONES, Gareth A</creator><creator>KEW, James N. C</creator><creator>CLUDERAY, Jane E</creator><general>Nature Publishing</general><scope>IQODW</scope></search><sort><creationdate>2008</creationdate><title>In Vitro and In Vivo Characterization of the Non-peptide N K3 Receptor Antagonist SB-223412 (Talnetant) : Potential Therapeutic Utility in the Treatment of Schizophrenia</title><author>DAWSON, Lee A ; CATO, Katherine J ; SOUTHAM, Eric ; MURKITT, Graham S ; GARTLON, Jane ; PEMBERTON, Darrel J ; JONES, Declan N. C ; DAVIES, Ceri H ; HAGAN, Jim ; SCOTT, Claire ; WATSON, Jeannette M ; WOOD, Martyn D ; FOXTON, Richard ; DE LA FLOR, Raul ; JONES, Gareth A ; KEW, James N. C ; CLUDERAY, Jane E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_203441013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Schizophrenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DAWSON, Lee A</creatorcontrib><creatorcontrib>CATO, Katherine J</creatorcontrib><creatorcontrib>SOUTHAM, Eric</creatorcontrib><creatorcontrib>MURKITT, Graham S</creatorcontrib><creatorcontrib>GARTLON, Jane</creatorcontrib><creatorcontrib>PEMBERTON, Darrel J</creatorcontrib><creatorcontrib>JONES, Declan N. C</creatorcontrib><creatorcontrib>DAVIES, Ceri H</creatorcontrib><creatorcontrib>HAGAN, Jim</creatorcontrib><creatorcontrib>SCOTT, Claire</creatorcontrib><creatorcontrib>WATSON, Jeannette M</creatorcontrib><creatorcontrib>WOOD, Martyn D</creatorcontrib><creatorcontrib>FOXTON, Richard</creatorcontrib><creatorcontrib>DE LA FLOR, Raul</creatorcontrib><creatorcontrib>JONES, Gareth A</creatorcontrib><creatorcontrib>KEW, James N. C</creatorcontrib><creatorcontrib>CLUDERAY, Jane E</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DAWSON, Lee A</au><au>CATO, Katherine J</au><au>SOUTHAM, Eric</au><au>MURKITT, Graham S</au><au>GARTLON, Jane</au><au>PEMBERTON, Darrel J</au><au>JONES, Declan N. C</au><au>DAVIES, Ceri H</au><au>HAGAN, Jim</au><au>SCOTT, Claire</au><au>WATSON, Jeannette M</au><au>WOOD, Martyn D</au><au>FOXTON, Richard</au><au>DE LA FLOR, Raul</au><au>JONES, Gareth A</au><au>KEW, James N. C</au><au>CLUDERAY, Jane E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Vitro and In Vivo Characterization of the Non-peptide N K3 Receptor Antagonist SB-223412 (Talnetant) : Potential Therapeutic Utility in the Treatment of Schizophrenia</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><date>2008</date><risdate>2008</risdate><volume>33</volume><issue>7</issue><spage>1642</spage><epage>1652</epage><pages>1642-1652</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><coden>NEROEW</coden><cop>New York, NY</cop><pub>Nature Publishing</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0893-133X |
| ispartof | Neuropsychopharmacology (New York, N.Y.), 2008, Vol.33 (7), p.1642-1652 |
| issn | 0893-133X 1740-634X |
| language | eng |
| recordid | cdi_pascalfrancis_primary_20344101 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Adult and adolescent clinical studies Biological and medical sciences Medical sciences Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychoses Schizophrenia |
| title | In Vitro and In Vivo Characterization of the Non-peptide N K3 Receptor Antagonist SB-223412 (Talnetant) : Potential Therapeutic Utility in the Treatment of Schizophrenia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T21%3A38%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Vitro%20and%20In%20Vivo%20Characterization%20of%20the%20Non-peptide%20N%20K3%20Receptor%20Antagonist%20SB-223412%20(Talnetant)%20:%20Potential%20Therapeutic%20Utility%20in%20the%20Treatment%20of%20Schizophrenia&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=DAWSON,%20Lee%20A&rft.date=2008&rft.volume=33&rft.issue=7&rft.spage=1642&rft.epage=1652&rft.pages=1642-1652&rft.issn=0893-133X&rft.eissn=1740-634X&rft.coden=NEROEW&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E20344101%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |